Preparations of the first line for atrial fibrillation of precurities in patients with minimal structural heart changes

Cover Page

Cite item

Full Text

Abstract

Atrial fibrillation is the most common arrhythmia in clinical practice. Number of patients with atrial fibrillation increases every year, primary due to the general aging of the population, as well as the presence of comorbidities. There are huge amount of research carried due to the search for optimal treatment and the most effective management of patients. In the given review the modern methods of the medicated sinus rhythm restoration and we analyzed updated recommendations of the Еuropean Society of Cardiology 2016 year.

About the authors

O. N Miller

Novosibirsk State Medical University of the Ministry of Health of the Russian Federation

Email: miller.olga@list.ru
д-р мед. наук, проф. каф. неотложной терапии, эндокринологии и проф. патологии ФПК и ППВ 630091, Russian Federation, Novosibirsk, Krasnyi pr-t, d. 52

A. V Tarasov

National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation

Email: a730tv@yandex.ru
канд. мед. наук, ст. науч. сотр., кардиолог-аритмолог, врач высшей категории. 101990, Russian Federation, Moscow, Petroverigskii per., d. 10, str. 3

E. N Pavenko

Novosibirsk State Technical University

Email: epav56@mail.ru
ст. преподаватель каф. АСУ 630073, Russian Federation, Novosibirsk, pr-t Karla Marksa, d. 20

References

  1. ESC. Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. doi: 10.1093/eurheartj/ehw210
  2. Руксин В.В. Краткое руководство по неотложной кардиологии. СПб.: ИнформМед, 2010; с. 63.]
  3. Sestito A, Molina E. Atrial fibrillation and the pharmacological treatment: the role of propafenone. Eur Rev Med Pharmacol Sci 2012; 16 (2): 242-53.
  4. Boriani G, Biffi M, Capucci A et al. Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized controlled trial. Ann Intern Med 1997; 126: 621-4.
  5. Capucci A, Villiani G, Aschieri D. Safety of oral propafenone in the convertion of recept-onset atrial fibrillation to sinus rhythm: a prospective parallel placebo - controlled multicentred study. Int J Cardiol 1999; 68: 187-96.
  6. Antonelli D, Darawsha A, Rimbrot S et al. Propafenone dose for emergency room conversion of paroxysmal atrial fibrillation. Harefuah 1999; 136 (11): 857-915.
  7. Khan I.A. Single oral loading dose of propafenone for pharmacological cardiover-sionofrecent-onsetatrial fibrillation. JACC 2001; 37: 542-7.
  8. Alboni P, Botto G.L, Baldi N et al. Outpatient treatment of recent-onset atrial fibrillation with the «pill-in-the-pocket» approach. N Engl J Med 2004; 351: 2384-91.
  9. Deneer V.H, Borgh M.B, Kingma J.H et al. Oral antiarrhythmic drugs in converting recent onset atrial fibrillation. Pharm World Sci 2004; 26 (2): 66-78.
  10. Bunin Y.А, Anfalova L. Efficacy of propafenone as single oral loading dose in pharmacology converting recent-onset atrial fibrillation and atrial flutter. Europace 2005; 7 (Suppl. 1): 121-2.
  11. Фомина И.Г., Таризманова А.И., Ветлужский А.В. и др. Пропафенон при восстановлении синусового ритма у больных с персистирующей формой фибрилляции предсердий. «ПРОМЕТЕЙ» - открытое, мультицентровое, пилотное исследование в Российской Федерации. Кардиоваск. терапия и профилактика. 2005; 4: 65-9.
  12. Zipes D.P. Management of cardiac arrhytmias: Parmacological, electrical and surgical techniques. In: E.Braunwald (ed). Heart disease-5th edition. Philadelphia 1997: p. 593-639.
  13. Feld G.K. Atrial fibrillation. Is there a safe and highly effective pharmacological treatment? Circulation 1990; 82: 2248-50.
  14. Leitch J.W, Klein G.J, Yee R. et al. Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern. Circulation 1990; 82: 1718-23.
  15. Martinez-Marcos F.J, Garcia-Garmendia J.L, Ortega-Carpio A. et al. Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. Am J Cardiol 2000; 86: 950-3.
  16. Chevalier P, Durand-Dubief A, Burri H et al. Amiodarone versus placebo and class IС drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. J Am Coll Cardiol 2003; 41 (2): 255-62.
  17. Stoschitzky K, Stoschitzky G, Lercher P et al. Propafenone shows class Ic and class II antiarrhythmic effects. Europace 2016; 18 (4): 568-71.
  18. Halpern S.W, Ellroot G, Singh B.N, Mandel W.J. Efficacy of intravenous procainamid infusion in converting atrial fibrillation to sinus rhythm. Relation to left atrium size. Brit Heart J 1980; 44: 589-95.
  19. Fenster P.E, Comess K.A, Marsh A et al. Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion. Am Heart J 1983; 106: 501-4.
  20. Kochiadakis G.E, Igoumenidis N.E, Solomou M.C et al. Conversion of atrial fibrillation to sinus rhythm using acute intravenous procainamide infusion. Cardiovasc Drugs Ther 1998; 12: 75-81.
  21. Kochiadakis G.E, Igoumenidis N.E, Hamilos M.E et al. A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onsetatrial fibrillation. Am J Cardiol 2007; 99: 1721-25.
  22. Stiell I.G, Clement C.M, Symington C et al. Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter. Acad Emerg Med 2007; 14: 1158-64.
  23. Singh S, Saini R.K, DiMarco J et al. Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group. Am J Cardiol 1991; 68: 1227-30.
  24. Noc M, Stajer D, Horvat M. Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm. Am J Cardiol 1990; 65: 679-80.
  25. Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebocontrolled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group. Eur Heart J 1997; 18: 649-54.
  26. Barroffio R, Tisi G, Guzzini F et al. A randomised study comparing digoxin and propafenone in the treatment of recent onset atrial fibrillation. Clin Drug Invest 1995; 9: 277-83.
  27. Hou Z.Y, Chang M.S, Chen C.Y et al. Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study. Eur Heart J 1995; 16: 521-8

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies